141 related articles for article (PubMed ID: 17428154)
1. Therapeutic drug monitoring of mycophenolic acid: does it improve patient outcome?
de Winter BC; Mathôt RA; van Hest RM; van Gelder T
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):251-61. PubMed ID: 17428154
[TBL] [Abstract][Full Text] [Related]
2. Pediatric aspects of therapeutic drug monitoring of mycophenolic acid in renal transplantation.
Tönshoff B; David-Neto E; Ettenger R; Filler G; van Gelder T; Goebel J; Kuypers DR; Tsai E; Vinks AA; Weber LT; Zimmerhackl LB
Transplant Rev (Orlando); 2011 Apr; 25(2):78-89. PubMed ID: 21454065
[TBL] [Abstract][Full Text] [Related]
3. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
[TBL] [Abstract][Full Text] [Related]
4. Graft outcome and mycophenolic acid trough level monitoring in kidney transplantation.
Sánchez Fructuoso AI; de la Higuera MA; Garcia-Ledesma P; Giorgi M; Ramos F; Calvo N; Pérez-Flores I; Barrientos A
Transplant Proc; 2009; 41(6):2102-3. PubMed ID: 19715843
[TBL] [Abstract][Full Text] [Related]
5. Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid.
van Gelder T; Tedesco Silva H; de Fijter JW; Budde K; Kuypers D; Arns W; Soulillou JP; Kanellis J; Zelvys A; Ekberg H; Holzer H; Rostaing L; Mamelok RD
Transplantation; 2010 Mar; 89(5):595-9. PubMed ID: 20124953
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials.
Barraclough KA; Isbel NM; Staatz CE
Transplantation; 2010 Jul; 90(1):44-51. PubMed ID: 20463644
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of mycophenolic acid in renal transplant recipients.
Okamoto M; Wakabayashi Y; Higuchi A; Kadotani Y; Ogino S; Ushigome H; Akioka K; Kaihara S; Yoshimura N
Transplant Proc; 2005 Mar; 37(2):859-60. PubMed ID: 15848556
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin.
Hiwarkar P; Shaw BE; Tredger JM; Brown NW; Kulkarni S; Saso R; Evans S; Treleaven J; Davies FE; Ethell ME; Morgan GJ; Potter MN
Clin Transplant; 2011; 25(2):222-7. PubMed ID: 20201951
[TBL] [Abstract][Full Text] [Related]
9. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.
van Hest RM; Mathot RA; Pescovitz MD; Gordon R; Mamelok RD; van Gelder T
J Am Soc Nephrol; 2006 Mar; 17(3):871-80. PubMed ID: 16452491
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.
Arns W; Cibrik DM; Walker RG; Mourad G; Budde K; Mueller EA; Vincenti F
Transplantation; 2006 Oct; 82(8):1004-12. PubMed ID: 17060847
[TBL] [Abstract][Full Text] [Related]
11. Lack of an effect of oral iron administration on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
Gelone DK; Park JM; Lake KD
Pharmacotherapy; 2007 Sep; 27(9):1272-8. PubMed ID: 17723081
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of mycophenolate mofetil in transplantation.
van Gelder T; Le Meur Y; Shaw LM; Oellerich M; DeNofrio D; Holt C; Holt DW; Kaplan B; Kuypers D; Meiser B; Toenshoff B; Mamelok RD
Ther Drug Monit; 2006 Apr; 28(2):145-54. PubMed ID: 16628123
[TBL] [Abstract][Full Text] [Related]
13. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
Kuypers DR; Le Meur Y; Cantarovich M; Tredger MJ; Tett SE; Cattaneo D; Tönshoff B; Holt DW; Chapman J; Gelder Tv;
Clin J Am Soc Nephrol; 2010 Feb; 5(2):341-58. PubMed ID: 20056756
[TBL] [Abstract][Full Text] [Related]
14. Can mycophenolic acid dose requirement during the first transplant help predict dosing for the second transplant?
Annapandian VM; Basu G; Mathew BS; Fleming DH; Jacob CK; John GT
Nephrol Dial Transplant; 2010 Oct; 25(10):3449-52. PubMed ID: 20647193
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.
Hulin A; Blanchet B; Audard V; Barau C; Furlan V; Durrbach A; Taïeb F; Lang P; Grimbert P; Tod M
Ther Drug Monit; 2009 Apr; 31(2):224-32. PubMed ID: 19214145
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients.
Prémaud A; Rousseau A; Le Meur Y; Venisse N; Loichot C; Turcant A; Hoizey G; Compagnon P; Hary L; Debruyne D; Saivin S; Jacqz-Aigrain E; Marquet P
Pharmacol Res; 2010 Feb; 61(2):167-74. PubMed ID: 19800973
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimen.
Royer B; Larosa F; Legrand F; Gerritsen-van Schieveen P; Bérard M; Kantelip JP; Deconinck E
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1134-9. PubMed ID: 19660728
[TBL] [Abstract][Full Text] [Related]
20. RELATE: Relationship of limited sampling strategy and adverse effects of mycophenolate mofetil in pediatric renal transplant patients.
Berger I; Haubrich K; Ensom MHH; Carr R
Pediatr Transplant; 2019 Mar; 23(2):e13355. PubMed ID: 30689262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
